CABiotech Profile Banner
California Biotech Profile
California Biotech

@CABiotech

Followers
7K
Following
86
Media
696
Statuses
2K

California's biotech & life science industry leads the world in life-saving cures for diseases that impact global communities.

California, USA
Joined May 2015
Don't wanna be here? Send us removal request.
@CABiotech
California Biotech
5 days
Qpex and @ShionogiUS have expanded their anti-infective discovery lab in San Diego—strengthening antimicrobial R&D with decades of expertise to advance next-generation treatments. 💉🔬. #CABiotech Learn more:
qpexbio.com
On April 17, 2025, Qpex and Shionogi celebrated the official opening of an expanded U.S.-based drug discovery laboratory in San Diego to support antimicrobial research and development (R&D) for...
0
0
0
@CABiotech
California Biotech
6 days
🚨Exciting news for CA: @Amgen investing $600M in new R&D hub in Thousand Oaks, bringing advanced tech to speed drug discovery — a big win for CA biotech. 🧬 Learn more:
Tweet card summary image
cnbc.com
It is the latest U.S. investment by a drugmaker as President Donald Trump threatens to impose tariffs on pharmaceuticals imported into the U.S.
2
0
2
@CABiotech
California Biotech
17 days
🌟New hope for head & neck cancer patients: @UCDavis is testing a first-of-its-kind treatment combining immunotherapy, radiation & a common blood pressure med. Early results show it’s safe and may shrink tumors. Learn more:
Tweet card summary image
health.ucdavis.edu
Cancer center scientists may have uncovered a breakthrough treatment for head and neck cancer using a common blood pressure medicine.
0
0
0
@CABiotech
California Biotech
20 days
The @US_FDA just approved a new, safer dosing schedule for @EliLillyandCo’s Alzheimer’s drug Kisunla. The change helps lower the risk of side effects by ~40%, while still helping clear harmful plaque. A step forward in Alzheimer’s care. Learn more:
Tweet card summary image
fiercepharma.com
The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA
0
0
1
@CABiotech
California Biotech
27 days
ICYMI: The @US_FDA has granted full approval of @Moderna_tx’s COVID-19 vaccine for kids 6 months-11years with underlying conditions. A big step forward in protecting our most vulnerable. Learn more:
biopharmadive.com
The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA vaccines in particular.
1
0
0
@CPAC
CPAC
1 month
Zohran Mamdani: He votes for activists, not you
50
48
197
@CABiotech
California Biotech
28 days
Today is World Breast Cancer Research Day, and CBF is spotlighting a breakthrough at Mayo Clinic—where the 1st patient in the U.S. received a new radioactive treatment for advanced breast cancer. Research makes treatment possible. ✨Learn more:
Tweet card summary image
kimt.com
Mayo Clinic says the therapy uses an alpha-emitting radiopharmaceutical designed to target cancer cells precisely without affecting healthy ones.
0
0
0
@CABiotech
California Biotech
1 month
Great conversations at our Life Science Industry Legislative Briefing! Thanks to our legislative co-conveners + speakers for highlighting how innovation & policy shape health, access and outcomes across CA. 🧠💡 #CALifeSciences
Tweet media one
Tweet media two
0
0
0
@CABiotech
California Biotech
2 months
🚨ICYMI: @BiocomCA released its 2025 Life Science Economic Impact Report. California’s life science industry generated $395.7B in business output last year and supported 1.15M jobs. A powerhouse for innovation and biomanufacturing! Learn more: https://t.co/FMtph6Eer7
Tweet media one
1
2
0
@CABiotech
California Biotech
2 months
💡.@UCSF researchers have developed the world's first shape-shifting synthetic proteins using AI, potentially revolutionizing medicine by creating novel treatments for diseases like cancer and Alzheimer's. Learn more:
Tweet card summary image
ucsf.edu
UCSF researchers recently created the world's first shape-shifting synthetic proteins using artificial intelligence (AI). The breakthrough opens the door to developing entirely new proteins that...
0
0
0
@DrRandallBock
Randall Bock
6 days
(it's 2025 and I have STILL to make a covid vaccine related... ) Request for Review of Removed Post Dear @LinkedIn Trust & Safety Team, I am writing to request a review of your recent decision to remove my post titled “COVID vaccine myths persist because officials suppress
Tweet media one
5
0
10
@CABiotech
California Biotech
2 months
A new CAR-T therapy offers hope for multiple myeloma patients, showing promising results in early trials. This personalized treatment uses engineered T-cells to target cancer, potentially transforming care for those with limited options. Learn more:
Tweet card summary image
nytimes.com
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death.
0
0
0
@CABiotech
California Biotech
2 months
The @US_FDA has cleared Clairity Breast—the first AI tool to predict 5-year breast cancer risk from routine mammograms. A major leap for personalized screening and early detection. Learn more:
Tweet card summary image
fiercebiotech.com
Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram.  | Startup...
0
0
0
@CABiotech
California Biotech
2 months
A @UCLA Health study finds that COVID-19 vaccinations may protect against severe kidney damage in hospitalized patients. Vaccinated individuals were significantly less likely to require advanced dialysis than unvaccinated ones. Read more:
nbcnews.com
Researchers at UCLA Health analyzed medical records of more than 3,000 patients who had been hospitalized for Covid between 2020 and 2022.
0
0
0
@CABiotech
California Biotech
2 months
⭐A breakthrough stem cell therapy helped a man with type 1 diabetes live insulin-free for over 2 years—a major step toward a cure and a testament to the promise of regenerative medicine. Learn more:
Tweet card summary image
nytimes.com
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
0
0
0
@CABiotech
California Biotech
3 months
🚨Big news: The @US_FDA approved @Gilead’s Yeztugo, a twice-yearly injection to prevent HIV. This marks a major milestone in the decades-long fight against HIV/AIDS, which contributed to 630,000 deaths in 2023. Learn more:
Tweet card summary image
cnbc.com
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts. 
1
0
0
@CABiotech
California Biotech
3 months
This #PrideMonth, CBF highlights @EdithPerezMD, a pioneering cancer researcher and equity advocate whose leadership has transformed breast cancer care and championed inclusion in science and medicine. Learn more: https://t.co/xkkg9TY8oF
Tweet media one
0
0
0
@CABiotech
California Biotech
3 months
A new COVID variant called “Nimbus” is spreading and causing a sharp, painful sore throat for many. Health experts emphasize the importance of testing, staying home when ill, and staying current on vaccines.
mercurynews.com
The newest variant, NB.1.8.1, also known as Nimbus, is now widespread in California.
1
0
0
@CABiotech
California Biotech
3 months
As #PrideMonth comes to a close, CBF celebrates Alaina Kupec, Executive Director of Portfolio Strategy & Analytics at @GileadSciences. Her leadership helps guide Gilead through critical decisions shaping the company’s development portfolio. https://t.co/6WGnUM6Nsv
Tweet media one
1
0
0
@CABiotech
California Biotech
3 months
As we continue to spotlight LGBTQ+ leaders this #PrideMonth, CBF honors Eric Dube, President & CEO of @TravereRare, whose experiences drive his mission to advance equity and innovation in biotech. https://t.co/N0tyTyQBeQ
Tweet media one
0
0
0
@CABiotech
California Biotech
3 months
A new CAR-T cell therapy is offering fresh hope to patients with multiple myeloma, even those who’ve exhausted other treatments. It’s a major milestone in the fight against this blood cancer. Learn more:
Tweet card summary image
nytimes.com
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death.
0
0
1